Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Multiple duodenal ulcers due to IgA vasculitis.

Journal of the Canadian Association of Gastroenterology·2026
Same author

Editorial: Systemic sclerosis: immunological impacts.

Frontiers in immunology·2026
Same author

The clinical utility of autoantibodies in systemic sclerosis: a review with a focus on cohort differences and standardization.

Frontiers in immunology·2025
Same author

A case of digital papillary adenocarcinoma with human papillomavirus 42 detected.

The Journal of dermatology·2024
Same author

Perspective to precision medicine in scleroderma.

Frontiers in immunology·2024
Same author

Augmented interferon I signaling in a patient with COVID toes.

The Journal of dermatology·2021

相关实验视频

Updated: Jul 5, 2026

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.7K

CD19:对于全身性硬化症来说是一个有希望的目标.

Kazuhiro Komura1

  • 1Department of Dermatology, Kanazawa Red Cross Hospital, Japanese Red Cross Society, Kanazawa, Ishikawa, Japan.

Frontiers in immunology
|October 18, 2024
PubMed
概括
此摘要是机器生成的。

针对B细胞的向疗法,如针对CD19的Uplizna® (伊内比利祖马布),在治疗全身性硬化症 (SSc) 方面表现有前途. 这些治疗可能会改善这种复杂的自身免疫性疾病患者的结果.

关键词:
CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19CD20 CD20 是一个CD20 CD20 是一个CD20.有纤维化的纤维化.系统性硬化症 系统性硬化症治疗疗法治疗疗法治疗疗法

更多相关视频

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.8K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

391

相关实验视频

Last Updated: Jul 5, 2026

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.7K
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.8K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

391

科学领域:

  • 免疫学 免疫学 免疫学
  • 类风湿病学 类风湿病学
  • 自免疫性疾病 自免疫性疾病

背景情况:

  • 系统性硬化症 (SSc) 是一种复杂的自身免疫性疾病,涉及免疫失调,血管损伤和纤维化.
  • B细胞是SSc病变的关键参与者,产生自身抗体并影响T细胞的反应.
  • 目前的治疗方法,如抗CD20疗法已经显示出好处,但正在探索新的点.

研究的目的:

  • 审查B细胞在全身性硬化症 (SSc) 中的作用.
  • 评估CD19向疗法的潜力,特别是Uplizna® (伊内比利祖马布),用于治疗SSc.
  • 讨论CD19针对性对CD20针对性在SSc管理中的优势.

主要方法:

  • 关于B细胞参与SSc.的文献综述
  • 对B细胞枯竭疗法 (rituximab,Uplizna®) 的现有数据的分析.
  • 讨论正在进行的临床试验Uplizna®在SSc.

主要成果:

  • 通过自身抗体和免疫调节,B细胞对SSc有显著的贡献.
  • CD19是一个有前途的B细胞标,像Uplizna®这样的疗法显示出潜力.
  • 与rituximab相比,Uplizna®可能在某些SSc患者亚组中提供更广泛的B细胞向和更高的疗效.

结论:

  • 针对CD19的疗法代表了SSc治疗的有希望的进步.
  • 需要进一步的研究来确定这些新疗法的长期安全性和有效性.
  • 向B细胞提供了一种潜在的途径,可以显著改善系统性硬化症的结果.